)
Fukuda Denshi (6960) investor relations material
Fukuda Denshi Q1 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Revenue for Q1 FY2027 was ¥30,985 million, up 2.0% year-over-year, with operating profit at ¥4,592 million, up 9.9%, and net profit attributable to shareholders at ¥3,079 million, up 8.8%.
The business environment remains uncertain due to global geopolitical risks, but the domestic economy is on a moderate recovery path.
Medical industry trends include digital transformation and regional healthcare collaboration.
Financial highlights
Gross profit for Q1 FY2027 was ¥16,814 million, with a gross margin of 54.3%.
Operating profit margin improved to 14.8% from 13.8% year-over-year.
Comprehensive income surged to ¥6,920 million, up 115.7% year-over-year.
EPS for Q1 FY2027 was ¥113.97, up from ¥100.87 in the prior year.
Outlook and guidance
Full-year FY2027 revenue forecast is ¥142,000 million (+1.6% YoY), with operating profit of ¥25,500 million (–4.2%), and net profit of ¥17,700 million (–5.8%).
No change to previously announced full-year guidance; Q1 results were in line with expectations.
The company notes that Q4 is typically the peak sales period.
- Modest sales and profit growth, with FY2027 guidance signaling lower earnings and a compliance incident.6960
Q4 2026 - Slight YoY profit decline offset by strong comprehensive income and stable full-year outlook.6960
Q3 2026 - Net sales up 0.8% and operating profit steady, with segment shifts and stable full-year outlook.6960
Q2 2026 - Sales rose 4% year-over-year, but profits declined; full-year guidance and dividends unchanged.6960
Q1 2025 - First-half profits fell on lower sales, but full-year guidance and dividend plans remain unchanged.6960
Q2 2025 - Profits declined despite stable sales, with mixed segment performance and steady full-year outlook.6960
Q3 2025 - Slight declines in sales and profit, with FY2026 guidance indicating further contraction.6960
Q4 2025 - Profits declined despite stable sales; medical treatment and consumables segments showed growth.6960
Q1 2026
Next Fukuda Denshi earnings date
Next Fukuda Denshi earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage